Visitor registration for the 23rd China International In Vitro Diagnostic Expo by CACLP is now officially open.

As part of promotional activities leading up to CACLP 2026, a series of activities took place successfully in Xiamen last week. Among them, the Xiamen Forum on Empowering the In Vitro Diagnostics Industry and Exploring New Models of Collaboration was held on 21 November 2025.

The first summit forum, Bode China In Vitro Diagnostic Industry Forum, hosted bythe Chinese Association for Clinical Laboratory Provider,that is scheduled to open in Jin Man Lou Grand Park Hotel, Ground Floor, International Conference Room

he congress haslots of leaders, experts and representatives from related Chinese governmentaldepartments and experimental medicine fields in both China and abroad. Thecongress is going to make some guiding reports around following topics: macrocountry

Download 第二届长白山体外诊断论坛参会回执.docx

Forum Name: The 2 nd Bode China In-Vitro Diagnostics Forum Forum Venue: Multi-Functional Hall (5 th Floor), Xiamen International Conference Exhibition Center Forum Date: March 17, 2015 Forum Time: 13:30-18:00 Forum Add: No.198 Conference Ex

?To whom it may concern： Leveraging upon CACLP Expo 2016,the 3 rd Bode China In-Vitro Diagnostics Industry Forum isscheduled to be held on March 6 th atBaihe room in QujiangInternational Conference Exhibition Center (F1). This time our

2016 March 6 th Xian 1. Forum Topic ? Chinese IVDs Innovation, Transition and Internet Plus in the New Normal. 2. Agenda Presenter Speech Time Topic Speaker Sun Yifeng 08:30-08:40 Forum chairman make opening speech Lian Xinting 08:40-09:1

The first summit forum, Bode China In Vitro Diagnostic Industry Forum, hosted bythe Chinese Association for Clinical Laboratory Provider,that is scheduled to open in Jin Man Lou Grand Park Hotel, Ground Floor, International Conference Room

Dear Exhibitors and Industry Colleagues, Many thanks for your strong support of CACLP Nanchang Expo 2020. With the recent situation caused of the Novel Coronavirus (2019-nCov), Chinese government has initiated the first-level response mecha

On February 7, 2014, China Food and Drug Administration (CFDA) issued the Special Review and Approval Procedure for Innovative Medical Devices (interim), which will be put into force as of March 1, 2014. The Procedure is an approval channel

Company: Kyowa Medex Website: www.kyowamx.co.jp Product: Determiner L HbA1c